Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEVOLEUCOVORIN vs LEVOMILNACIPRAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEVOLEUCOVORIN vs LEVOMILNACIPRAN: Safety Overview

Metric LEVOLEUCOVORIN LEVOMILNACIPRAN
Total FAERS Reports 3,168 1,378
Deaths Reported 421 382
Death Rate 13.3% 27.7%
Hospitalizations 1,413 378
Average Patient Age 64.9 yrs 46.4 yrs
% Female Patients 36.1% 80.2%
FDA Approval Date Apr 29, 2011 Feb 4, 2019
Manufacturer Hikma Pharmaceuticals USA Inc. Allergan, Inc.
Route INTRAVENOUS ORAL
Marketing Status Discontinued Prescription